Skip to main content
TipRanks
Go Ultimate75% OFF

George Whitesides Insider Profile

4 Followers

George Whitesides, Director at Lyra Therapeutics, holds 249.08K shares in Theravance Biopharma (Ticker: TBPH), holds 55.06K shares in Lyra Therapeutics (Ticker: LYRA), holds 776.70K shares in Innoviva (Ticker: INVA).

George Whitesides's Trading History

TBPH
Theravance Biopharma
Apr 29, 2021―Uninformative Buy―$4.24M
LYRA
Lyra Therapeutics
May 06, 2020DirectorUninformative Buy―$1.65K
INVA
Innoviva
May 27, 2014DirectorUninformative Buy―$14.36M
AMAG
Amag Pharmaceuticals
―――$0.00

You May Also Like

George Whitesides insider profile FAQ

What is the percentage of profitable transactions made by George Whitesides?
The percentage of profitable transactions made by George Whitesides is 0%.
What is the average return per transaction made by George Whitesides?
The average return per transaction made by George Whitesides is -12.90%.
What stocks does George Whitesides hold?
George Whitesides holds: LYRA, TBPH, INVA, AMAG stocks.
What was George Whitesides's most profitable transaction?
George Whitesides’s most profitable transaction was an Informative Buy of TBPH stock on August 14, 2017. The return on the trade was 0.00%.
What is George Whitesides's role in Lyra Therapeutics?
George Whitesides's role in Lyra Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.